Activation of the Wnt/β‐catenin pathway represses the transcription of the β‐amyloid precursor protein cleaving enzyme (BACE1) via binding of T‐cell factor‐4 to BACE1 promoter
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Alterations in the Wnt signaling pathway have been implicated in Alzheimer's disease; however, its role in the processing of the amyloid precursor protein remains unknown. In this study, activation of the Wnt pathway by overexpression of the agonist Wnt3a or β‐catenin or by inhibition of glycogen kinase synthase‐3 in N2a cells resulted in a reduction in Aβ levels and in the activity and expression of BACE1 (β‐APP cleaving enzyme). Conversely, inhibition of the pathway by transfection of the antagonists secreted frizzled receptor protein‐1 or dickkopf‐1 produced the opposite effects. Chromatin immunoprecipitation analysis demonstrated that β‐catenin binds specifically to regions within the promoter of BACE1 containing putative T‐cell factor/lymphoid enhancer binding factor‐1 (TCF/LEF) motifs, consistent with canonical Wnt target regulation. Furthermore, cells transfected with β‐catenin mutants incapable of binding to TCF/LEF increased BACE1 gene promoter activity. Interestingly, TCF4 knockdown reversed the effects of Wnt3a activation on BACE1 transcription. We found that TCF4 binds to the same region on BACE1 promoter following Wnt3a stimulation, indicating that TCF4 functions as a transcriptional repressor of BACE1 gene. In conclusion, Wnt/β‐catenin stimulation may repress BACE1 transcription via binding of TCF4 to BACE1 gene, and therefore, activation of the Wnt pathway may hold the key to new treatments of Alzheimer disease.—Parr, C., Mirzaei, N., Christian, M., and Sastre, M. Activation of the Wnt/β‐catenin pathway represses the transcription of the β‐amyloid precursor protein cleaving enzyme (BACE1) via binding of T‐cell factor‐4 to BACE1 promoter. FASEB J . 29, 623‐635 (2015). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Bafico, A., Liu, G., Yaniv, A., Gazit, A., & Aaronson, S. A. (2001) · Nature Cell Biology · doi:10.1038/35083081 · Cited by 772
Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis
Kuwabara, T., Hsieh, J., Muotri, A., Yeo, G., Warashina, M., Lie, D. C., Moore, L., Nakashima, K., Asashima, M., & Gage, F. H. (2009) · Nature Neuroscience · doi:10.1038/nn.2360 · Cited by 648
Zeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., Yokota, C., Almeida, K., Wang, J., Doble, B., Woodgett, J., et al. (2008) · Development · doi:10.1242/dev.013540 · Cited by 492
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Ly, P. T. T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64516 · Cited by 442 · cited 2×
“The reduction of BACE1 transcription is in agreement with a recent study that found decreased BACE1 levels after GSK3 inhibition (36).”
BackgroundResultInteraction of Nuclear Receptors with the Wnt/β-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Mulholland, D. J., Dedhar, S., Coetzee, G. A., & Nelson, C. C. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0034 · Cited by 377 · cited 1×
“Another potential mechanism for the regulation of BACE1 transcription by the canonical Wnt pathway could be through the interactions of b-catenin with nuclear receptors (30, 43), such as the retinoic acid receptor, the estrogen receptor, and the peroxisome proliferatoractivated receptors, which have been reported to a…”
BackgroundHeneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., & Van Leuven, F. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-22 · Cited by 309 · cited 1×
“performedusinga syntheticpeptide containing the specific b-cleavage site, which has previously been shown to be highly specific (28), and showed around 50% decrease in b-secretase activity in cells overexpressing b-catenin S33 (Fig.”
Self-citationClusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
Killick, R., Ribe, E. M., Al-Shawi, R., Malik, B., Hooper, C., Fernandes, C., Dobson, R., Nolan, P. M., Lourdusamy, A., Furney, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.163 · Cited by 222 · cited 2×
“The mechanism by which Ab induces neuronal toxicity has shown to be mediated through the Ab induction of CLUSTERIN, which activates DKK-1 leading to an activation of a Wnt–planar cell polarity (PCP)-c-Jun terminal kinase (JNK) signaling pathway (25).”
BackgroundThe secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss
Purro, S. A., Dickins, E. M., & Salinas, P. C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4562-11.2012 · Cited by 195 · cited 2×
“DKK-1 was recently demonstrated to be required for Ab-mediated synaptic loss (24).”
BackgroundWexler, E. M., Rosen, E., Lu, D., Osborn, G. E., Martin, E., Raybould, H., & Geschwind, D. H. (2011) · Science Signaling · doi:10.1126/scisignal.2002282 · Cited by 56 · cited 1×
“In line with our data, a recent unbiased systems biology approach identified BACE1, among several AD-associated genes, as direct targets of canonical Wnt induction, such as APP, presenilin-1 (PS1), and death receptor-6 (DR6 ) in addition to the frontotemporal dementia-associated microtubule-associated protein tau (MAP…”
Background
Cited by
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
Jia, L., Piña-Crespo, J., & Li, Y. (2019) · Molecular Brain · doi:10.1186/s13041-019-0525-5 · Cited by 288
“AD: Alzheimer’s disease; ADAM10: The disintegrin and metalloproteinase domain 10 protein; ApoE4: Apolipoprotein E4; APP: Amyloid precursor protein; ASO: Anti-sense oligonucleotides; BACE1: The β-site APP cleaving enzyme; BBB: Blood-brain barrier; CBP: CAMP-response element-binding protein (CREB)-binding protein; DKK:…”
BackgroundWnt signaling deregulation in the aging and Alzheimer’s brain
Palomer, E., Buechler, J., & Salinas, P. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00227 · Cited by 237
Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer’s disease.
Inestrosa, N., & Tapia-Rojas, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238606 · Cited by 137
Petrache, A. L., Rajulawalla, A., Shi, A., Wetzel, A., Saito, T., Saido, T. C., Harvey, K., & Ali, A. B. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz016 · Cited by 124
“…ligand or DKK1 inhibitors might alleviate some of the observed neuronal changes in the APPNL-F/NL-F animals (Alvarez et al. 2004; Toledo and Inestrosa 2010; Fiorentini et al. 2010; Harvey and Marchetti 2014; Yi et al. 2014; Parr et al. 2015; Marzo et al. 2016; Jin et al. 2017, Huang et al. 2018).”
BackgroundImpaired Wnt Signaling in the Prefrontal Cortex of Alzheimer’s Disease
Folke, J., Pakkenberg, B., & Brudek, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1103-z · Cited by 123
Metadata
- Authors
- Parr, C., Mirzaei, N., Christian, M., & Sastre, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2014-11-10
- Volume
- 29
- Issue
- 2
- Pages
- 623-635
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2083670710
- Cited by
- 113
- References
- 11
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.